source
- Elicio’s KRAS cancer vaccine fails in Phase 2, shares plummetElicio Therapeutics’ pancreatic cancer vaccine failed to improve outcomes in a mid-stage study, but the company is seeking funds to move ahead to a larger Phase 3 trial anyway. Elicio reported ...Endpoints · 2mo ago↗ source
- STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to endAfter July 1, Medicare will offer GLP-1 weight-loss drugs for $50. It's supposed to be temporary, but chances are it won't be.STAT · 2mo ago↗ source
- Gan & Lee's Phase 3 obesity successes; J&J touts multiple myeloma dataPlus news about Sanofi, PharmaMar, Jazz, Rhythm Pharmaceuticals, Spyre and Zymeworks 🇨🇳 Another obesity readout from China: Gan & Lee Pharmaceuticals, a China-based insulin specialist, announced…